US Plan Offers Big Savings On Rx OCs
US benefit manager FFI Health Services says that in the six months since its femScript program was set up, over 20,000 women have enrolled, cutting their prescription oral contraceptive costs by almost half.
The company says that while many insurance plans do not cover these products' expenses, every new and refill prescription for products covered by femScript qualifies for savings of at least 45%. Last month, Cosmopolitan magazine reported that one month's supply of a particular brand in a non-femScript pharmacy cost $26.96 a month, while femScript members could obtain a three-month supply for $36, saving $44.88.
Over 15,000 pharmacies nationwide are participating in the femScript program, according to FFI. Members pay an annual fee of $9.95, and receive a membership card to present with their doctor's prescription at participating pharmacies.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze